Repeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...
Read moreDetailsAustralian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...
Read moreDetailsEyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited